Determination of serum tetranectin: Technical and clinical evaluation of three sandwich immunoassays

Clinica Chimica Acta

Volumn 276, Issue 1, 1998, Pages 19-34

  Thougaard, Annemette V ^a,e   K Høgdall, Claus ^b   Kjær, Susanne K ^c   Jan Blaakaer ^d   Jaliashvili, Irakli ^e   Christiansen, Michael ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Juliane Marie Centret R ^*  (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

C type lectin; Method comparison; Ovarian cancer; Tumour marker

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TETRANECTIN; TUMOR MARKER;

ACCURACY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; STANDARD;

ADULT; AGED; ANIMALS; BLOOD PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LECTINS; LECTINS, C-TYPE; MALE; MICE; MIDDLE AGED; OVARIAN NEOPLASMS; RABBITS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0031839460     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00092-8     Document Type: Article

References (28)

1. Clemmensen I., Petersen L.C., Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem. 156:1986;327-333.
2. Christensen L., Johansen N., Jensen B.A., Clemmensen I. Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry. 87:1987;195-199.
3. Christensen L., Clemmensen I. Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry. 92:1989;29-35.
4. Berglund L., Petersen T.E. The gene structure of tetranectin, a plasminogen binding protein. FEBS Lett. 309:1992;15-19.
5. Neame P.J., Young C.N., Treep J.T. Primary structure of a protein isolated from reef shark (Carcharhinus springeri) cartilage that is similar to the mammalian C-type lectin homolog, tetranectin. Prot Sci. 1:1992;161-168.
6. Holtet T.L., Graversen J.H., Clemmensen I., Thøgersen H.C., Etzerodt M. Tetranectin, a trimeric plasminogen binding C-type lectin. Prot Sci. 6:1997;1-5.
7. Nielsen B.B., Kastrup J.S., Rasmussen H.et al. Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an x-helical coiled coil. FEBS Lett. 412:1997;388-396.
8. Clemmensen I. Interaction of tetranectin with sulphated polysaccharides and trypan blue. Scand J Clin Lab Invest. 49:1989;719-725.
9. Wewer U.M., Albrechtsen R. Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer. Lab Invest. 67:1992;253-262.
10. De Vries T.J., De Wit P.E.J., Clemmensen I.et al. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol. 179:1996;260-265.
11. Wewer U.M., Ibaraki K., Schjørring P., Durkin M.E., Young M.F., Albrechtsen R. A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol. 127:1994;1767-1775.
12. 1 downregulates dexamethasone-induced tetranectin gene expression during the in vitro mineralization of the human osteoblastic cell line SV-HFO. FEBS Lett. 373:1995;1-4.
13. Nielsen H., Clemmensen I., Nielsen H.J., Drivsholm Aa. Decreased tetranectin in multiple myeloma. Am J Hematol. 33:1990;142-144.
14. Verspaget H.W., Clemmensen I., Ganesh S.et al. Tetranectin expression in human colonic neoplasia. Histopathology. 25:1994;463-467.
15. Høgdall C.K., Christiansen M., Nørgaard-Pedersen B., Bentzen S.M., Kronborg O., Clemmensen I. Plasma tetranectin and colorectal cancer. Eur J Cancer. 31:1995;888-894.
16. Jensen B.A., Clemmensen I. Plasma tetranectin is reduced in cancer and related to metastasia. Cancer. 62:1988;869-872.
17. Høgdall C.K., Høgdall E.V.S., Hørding U.et al. Plasma tetranectin and ovarian neoplasms. Gynecol Oncol. 43:1991;103-107.
18. Høgdall C.K., Sölétormos G., Nielsen D., Nørgaard-Pedersen B., Dombernowsky P., Clemmensen I. Prognostic value of serum tetranectin in patients with metastatic breast cancer. Acta Oncol. 32:1993;631-636.
19. Høgdall C.K., Christensen L., Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer. 72:1993;2415-2422.
20. Høgdall C.K., Hørding U., Nørgaard-Pedersen B., Toftager-Larsen K., Clemmensen I. Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients. Eur J Obstet Gynecol Reprod Biol. 57:1994;175-178.
21. Fuhlendorff J., Clemmensen I., Magnusson S. Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: Homology with asialoglycoprotein receptors and cartilage proteoglycan core protein. Biochemistry. 26:1987;6757-6764.
22. Swiss Institute for Experimental Cancer Research; BLAST network service for amino acid sequence analysis.
23. Høgdall C.K., Christiansen M., Christensen L.et al. Monoclonal antibodies against human tetranectin, epitope characterization and use in immunohistochemistry. Clin Chim Acta. 258:1997;159-177.
24. Jensen B.A., McNair P., Hyldstrup L., Clemmensen I. Plasma tetranectin in healthy male and female individuals, measured by enzyme-linked immunosorbent assay. J Lab Clin Med. 110:1987;612-617.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-310.
26. Davies C. Concepts. In: Wild D. ed. The immunoassay handbook. London: Macmillan Press Ltd., 1994:97.
27. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991:139.
28. Høgdall C.K. Stability of tetranectin concentration in blood samples. Fibrinolysis. 8:1994;101-103.